Vav3, a GEF for RhoA, Plays a Critical Role under High Glucose Conditions

다국어 초록 (Multilingual Abstract)

Background: The role of small GTPase molecules is poorly understood under high glucose conditions.
Methods: We analyzed the expression pattern of Vav3 in skeletal muscle C2C12 cells under high glucose culture condition with reverse transcription-polymerase chain reaction and Western blot analysis. We also measured glucose uptake using isotope-labelled glucose.
Results: We showed that expression of Vav3 (a guanine nucleotide exchange factor for RhoA) increased. mRNA and protein levels in skeletal muscle C2C12 cells under high glucose conditions. The AMP-activated protein kinase (AMPK) activator AMPK agonist 5-aminoimidazole-4-carboxy-amide-1-d-ribofuranoside (AICAR) suppressed high glucose-induced Vav3 induction. In addition, exposure of cells to high glucose concentration increased the phosphorylation of PAK-1, a molecule downstream of RhoA. The phosphorylation of paxillin, a downstream molecule of PAK-1, was also increased by exposure to high glucose. Phosphorylation of these molecules was not observed in the presence of AICAR, indicating that AMPK is involved in the RhoA signal pathway under high glucose conditions. Knock down of Vav3 enhances metformin-mediated glucose uptake. Inhibition of AMPK blocked the increases of Vav3 knock down-induced glucose uptake. Metformin-mediated Glut4 translocation was also increased by Vav3 knock-down, suggesting that Vav3 is involved in metformin-mediated glucose uptake.
Conclusion: These results demonstrate that Vav3 is involved in the process of metformin-mediated glucose regulation.

참고문헌 (Reference)

1 Katzav S, "vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells" 8 : 2283-2290, 1989

2 Moores SL, "Vav family proteins couple to diverse cell surface receptors" 20 : 6364-6373, 2000

3 Makinde AO, "Upregulation of 5’-AMP-activated protein kinase is responsible for the increase in myocardial fatty acid oxidation rates following birth in the newborn rabbit" 80 : 482-489, 1997

4 Cichowski K, "Thrombin receptor activation and integrin engagement stimulate tyrosine phosphorylation of the proto-oncogene product, p95vav, in platelets" 271 : 7544-7550, 1996

5 Adams JM, "The hematopoietically expressed vav proto-oncogene shares homology with the dbl GDP-GTP exchange factor, the bcr gene and a yeast gene (CDC24) involved in cytoskeletal organization" 7 : 611-618, 1992

6 Wang Y, "The effect of metformin on insulin receptor protein tyrosine kinase activity of HIT-T15 cell exposed to high concentration glucose and free fatty acid" 38 : 819-821, 2007

7 Hardie DG, "The AMP-activated protein kinase: fuel gauge of the mammalian cell?" 246 : 259-273, 1997

8 JeBailey L, "Skeletal muscle cells and adipocytes differ in their reliance on TC10 and Rac for insulin-induced actin remodeling" 18 : 359-372, 2004

9 Han J, "Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav" 279 : 558-560, 1998

10 Burridge K, "Rho and Rac take center stage" 116 : 167-179, 2004

11 Bustelo XR, "Regulatory and signaling properties of the Vav family" 20 : 1461-1477, 2000

12 Ju JS, "Potentiation of insulin-stimulated glucose transport by the AMP-activated protein kinase" 292 : C564-C572, 2007

13 Despres JP, "Potential contribution of metformin to the management of cardiovascular disease risk in patients with abdominal obesity, the metabolic syndrome and type 2 diabetes" 29 (29): 6S53-6S61, 2003

14 Bailey CJ, "Metformin: effects on micro and macrovascular complications in type 2 diabetes" 22 : 215-224, 2008

15 Borst SE, "Metformin, but not exercise training, increases insulin responsiveness in skeletal muscle of Sprague-Dawley rats" 69 : 1497-1507, 2001

16 Yoshida T, "Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type 2 diabetes Goto-Kakizaki rats" 623 : 141-147, 2009

17 He L, "Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein" 137 : 635-646, 2009

18 Wiernsperger NF, "Membrane physiology as a basis for the cellular effects of metformin in insulin resistance and diabetes" 25 : 110-127, 1999

19 Katzav S, "Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential" 11 : 1912-1920, 1991

20 Kooy A, "Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus" 169 : 616-625, 2009

21 Schuebel KE, "Isolation and characterization of murine vav2, a member of the vav family of proto-oncogenes" 13 : 363-371, 1996

22 Henin N, "Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP-activated protein kinase" 9 : 541-546, 1995

23 Miranti CK, "Identification of a novel integrin signaling pathway involving the kinase Syk and the guanine nucleotide exchange factor Vav1" 8 : 1289-1299, 1998

24 Henske EP, "Identification of VAV2 on 9q34 and its exclusion as the tuberous sclerosis gene TSC1" 59 (59): 25-37, 1995

25 Teranishi T, "Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus" 56 : 1418-1424, 2007

26 Ai H, "Effect of fiber type and nutritional state on AICAR- and contraction-stimulated glucose transport in rat muscle" 282 : E1291-E1300, 2002

27 Ueda S, "Crucial role of the small GTPase Rac1 in insulin-stimulated translocation of glucose transporter 4 to the mouse skeletal muscle sarcolemma" 24 : 2254-2261, 2010

28 Gotoh A, "Cross-linking of integrins induces tyrosine phosphorylation of the proto-oncogene product Vav and the protein tyrosine kinase Syk in human factor-dependent myeloid cells" 8 : 721-729, 1997

29 Pryor PR, "Chronic insulin effects on insulin signalling and GLUT4 endocytosis are reversed by metformin" 348 (348): 83-91, 2000

30 JeBailey L, "Ceramide- and oxidant-induced insulin resistance involve loss of insulin-dependent Rac-activation and actin remodeling in muscle cells" 56 : 394-403, 2007

31 Siegel Gj, "Basic Neurochemistry" Lippincott-Raven 637-670, 1999

32 Bailey CJ, "Avandamet: combined metformin-rosiglitazone treatment for insulin resistance in type 2 diabetes" 58 : 867-876, 2004

33 Zheng L, "Antibody-induced engagement of beta 2 integrins on adherent human neutrophils triggers activation of p21ras through tyrosine phosphorylation of the protooncogene product Vav" 93 : 8431-8436, 1996

34 Ueda S, "Activation of the small GTPase Rac1 by a specific guanine-nucleotide-exchange factor suffices to induce glucose uptake into skeletal-muscle cells" 100 : 645-657, 2008

35 Fisher JS, "Activation of AMP kinase enhances sensitivity of muscle glucose transport to insulin" 282 : E18-E23, 2002

36 Zong H, "AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation" 99 : 15983-15987, 2002

37 Iglesias MA, "AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats" 51 : 2886-2894, 2002